During the past decade, Regional Clinical Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regional Clinical Hospital" #1 sponsor was "Celgene" with 5 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Clinical Hospital" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator and "KCRI" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Regional Clinical Hospital" are "Ulcerative Colitis" (3 trials), "Angina" (1 trials), "Angina Pectoris" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Regional Clinical Hospital" are "Drug" (11 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Lenalidomide" (3 trials), "Mesalamine" (2 trials), "AG-221" (1 trials) and "Alteplase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Clinical Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Regional Clinical Hospital". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Regional Clinical Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".